Related references
Note: Only part of the references are listed.Differentiation-associated miR-22 represses Max expression and inhibits cell cycle progression
Yi Ting et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Novel steroid carbamates reverse multidrug-resistance in cancer therapy and show linkage among efficacy, loci of drug action and P-glycoprotein's cellular localization
Mirit Argov et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2010)
Inhibition of phosphatidylinositol 3-kinase promotes tumor cell resistance to chemotherapeutic agents via a mechanism involving delay in cell cycle progression
Gail T. McDonald et al.
EXPERIMENTAL CELL RESEARCH (2010)
Tumor-suppressive microRNA-22 inhibits the transcription of E-box-containing c-Myc target genes by silencing c-Myc binding protein
J. Xiong et al.
ONCOGENE (2010)
miR-22 Forms a Regulatory Loop in PTEN/AKT Pathway and Modulates Signaling Kinetics
Nadav Bar et al.
PLOS ONE (2010)
Colorectal cancer in Guangdong Province of China: A demographic and anatomic survey
An-Gao Xu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2010)
Can the Status of the Breast and Ovarian Cancer Susceptibility Gene 1 Product (BRCA1) Predict Response to Taxane-Based Cancer Therapy?
J. Thomas DeLigio et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2009)
MTDH Activation by 8q22 Genomic Gain Promotes Chemoresistance and Metastasis of Poor-Prognosis Breast Cancer
Guohong Hu et al.
CANCER CELL (2009)
Induction of Akt Activity by Chemotherapy Confers Acquired Resistance
Wei-Chien Huang et al.
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2009)
Astrocyte elevated gene-1 activates cell survival pathways through PI3K-Akt signaling
S-G Lee et al.
ONCOGENE (2008)
Targeting Akt to increase the sensitivity of neuroblastoma to chemotherapy: lessons learned from the brain-derived neurotrophic factor/TrkB signal transduction pathway
Zhijie Li et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2007)
The resurgence of platinum-based cancer chemotherapy
Lloyd Kelland
NATURE REVIEWS CANCER (2007)
Chemoresistant KM12C colon cancer cells are addicted to low cyclic AMP levels in a phosphodiesterase 4-regulated compartment via effects on phosphoinositide 3-kinase
David G. McEwan et al.
CANCER RESEARCH (2007)
In vitro and in vivo synergy of MCP compounds with mitogen-activated protein kinase pathway- and microtubule-targeting inhibitors
Natalia Skobeleva et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Astrocyte elevated gene-1 (AEG-1) is a target gene of oncogenic Ha-ras requiring phosphatidylinositol 3-kinase and c-Myc
Seok-Geun Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Control of translation and mRNA degradation by miRNAs and siRNAs
MA Valencia-Sanchez et al.
GENES & DEVELOPMENT (2006)
PI3 kinase involves in cocaine behavioral sensitization with receptor and brain region specificity
XW Zhang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Activation of the nuclear factor κB pathway by astrocyte elevated gene-1:: Implications for tumor progression and metastasis
L Emdad et al.
CANCER RESEARCH (2006)
H1 RNA polymerase III promoter-driven expression of an RNA aptamer leads to high-level inhibition of intracellular protein activity
Jing Mi et al.
NUCLEIC ACIDS RESEARCH (2006)
The TP53 Colorectal Cancer International Collaborative Study on the prognostic and predictive significance of p53 mutation:: Influence of tumor site, type of mutation, and adjuvant treatment
A Russo et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Mechanism of HIF-1α-dependent suppression of hypoxia-induced apoptosis in squamous cell carcinoma cells
E Sasabe et al.
CANCER SCIENCE (2005)
Share Paper
